学术动态-en Group published“RIG-I-inducing Small Molecules Potently Inhibit HMA-resistant AML through Igniting the Overloaded dsRNA Arsenal”on《Advanced Science》 2025年6月17日
学术动态-en The research group published in Fundamental Research in 2025, titled ‘p53 mutation associated diagnosis across cancer types, underlying hematological malignancy as an applicable cancer type to p53 rescue therapy’ 2025年6月17日
学术动态-en The clinical research standards for P53 restorer proposed by the research group in 2025 were published in Nat Rev Cancer 2025年5月16日
学术动态-en In 2024, Professor Lu Min, the leader of the research group, was awarded the Youth Science Foundation Project (Class A) 2025年5月15日
学术动态-en Dr. Chen Xueqin from the research group successfully completed his graduation defense and became a postdoctoral fellow in the research group 2025年5月12日
学术动态-en In 2024, Chen Xueqin was awarded the National Natural Science Foundation’s Young Student Program (PhD Program) 2024年12月11日
学术动态-en Researcher Lu Min shares the science popularization of “Cancer and Cancer Targeted Drugs” at the “Marine Science Popularization Lecture” 2024年4月28日
学术动态-en 2019 doctoral student Xiao Shujun was awarded the title of “Shanghai Outstanding Doctoral Graduate” and “Shanghai Jiao Tong University Outstanding Doctoral Graduate” in 2024 2024年4月28日